Reprogenix
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $70M
Investors
- 13
About Reprogenix
, doing business as Reprogenix, specializes in the development of cell therapy solutions. The company has undergone strategic pivots to enhance its operational capabilities. The company possesses an independently developed innovative technology platform for human pluripotent stem cells, including a stem cell line establishment platform, a stem cell directed differentiation platform, a gene editing platform, a molecular detection platform, a single-cell detection platform, and a sequencing data analysis platform. It has also independently developed products such as RGB5088 pancreatic islet cell injection. The company generates revenue by developing and providing stem cell regenerative medicine and other related products.
Who invested in Reprogenix
13 investors across 2 rounds
See all investors in Reprogenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Reprogenix
Who invested in Reprogenix?
Reprogenix has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reprogenix raised?
Reprogenix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Reprogenix last raise money?
Reprogenix's most recent round on record is a Series A, in Nov 2025.
What does Reprogenix do?
, doing business as Reprogenix, specializes in the development of cell therapy solutions.
Where is Reprogenix headquartered?
Reprogenix is headquartered in Hangzhou, China.
Which VCs invest in companies like Reprogenix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Reprogenix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Reprogenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.